"This glycosylation of alpha-gal is not seen in ... They sought to test whether pre-existing IgE to alpha-gal might explain why some patients experience a first-dose reaction to ustekinumab.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback